Sunday, July 20, 2025 | 07:02 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

World Coronavirus Dispatch: Secret ingredients behind vaccine breakthrough

Religious leaders are strongly resisting Covid restrictions, Hong Kong and Singapore are scheduled to test the world's first comprehensive quarantine free air-travel bubble on November 22, and more

coronavirus
premium

A heath worker prepares the injection site on a patient's arm for administration of the Sputnik V vaccine during a trial in Moscow, on Sept. 23. (Photo: Andrey Rudakov/Bloomberg)

Akash Podishetty Hyderabad
Pfizer moved to seek emergency authorisation of its Covid-19 vaccine from the US drug regulator, after trials proved over 95 per cent efficacy in preventing infections. The move marks a milestone in months of frantic global hunt for a medicine that could check the pandemic. Once the company files for approval, it is upto the regulator to decide whether the vaccine works safely and is fit for public use. It's also unclear how much time the agency will take to analyse the vaccine data.

Let's look at global statistics

Global infections: 57,564,688

Change over yesterday: 642,538

Global deaths: 1,372,182

Nations with most cases: US